Press releases
- Press releases
- Browse
Press releases
Pharmalicensing launches revised versions of its Deals Briefings with up-to-date data More
New edition of Partneringreview summarizes pharma and biotech deals of 2005 More
Partneringdesk Deals and Alliances therapy reports are revised with up-to-date deals More
Canada's lacklustre pace in adopting health innovations and commercializing new products and processes is costing our health system, according to organizers of a Richard Ivey School of Business conference taking place next week. More
New agreement in Animal Health area More
We offer complete global expert pharmacovigilance support to small and midsize companies, and project specific pharmacovigilance assistance to big pharmaceutical companies. More
Drug desensitization is an overlooked side effect of many drugs. Desensitization often contributes to a person's inability to tolerate many common medications including those for the heart, pain or asthma. More
New edition of Partneringreview summarizes pharma and biotech deals of 2005 More
Agreement between Medincell and Novartis Animal Health More
MARKETREADY(TM): a comprehensive, step-by-step process to help meet regulatory standards in pre-approval inspections. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 124 pages - $1,740
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Jun 2009 - 110 pages - $1,040
Dec 2006 - 90 pages - $995
Oct 2011 - 64 pages - $500
Jun 2009 - 472 pages - $3,140
Jun 2008 - 175 pages - $3,835
Apr 2010 - 510 pages - $2,695
Nov 2010 - 428 pages - $2,695
Your selection
Browse By
- Industry sector
- Intravesical
- Nasal
- Nasal topical
- Ophthalmic
- Oral liquid
- Oral solid
- Otic
- Parenteral
- Pulmonary
- Rectal
- Systemic
- Topical
- Vaginal
- Therapeutic target
- Auditory
- Opthalmic
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us